PIK3CA and metastatic malignant neoplasm in the lymph nodes: Whether PIK3CA gene mutation has a significant relation with clinicopathological characteristics such as age, differentiation, and lymph node metastasis and whether it could affect the survival of NSCLC patients are unclear up to now.